PRELUDE CAPITAL MANAGEMENT, LLC - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 152 filers reported holding THERAPEUTICSMD INC in Q2 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q4 2021$4,000
-71.4%
11,000
+6.8%
0.00%
Q1 2021$14,000
+1300.0%
10,300
+1371.4%
0.00%
Q3 2020$1,0000.0%7000.0%0.00%
Q2 2020$1,000
-66.7%
700
-50.7%
0.00%
Q4 2019$3,000
-50.0%
1,421
-9.9%
0.00%
Q3 2019$6,000
+50.0%
1,577
-2.7%
0.00%
Q2 2019$4,000
+300.0%
1,620
+639.7%
0.00%
Q4 2018$1,000
-96.4%
219
-91.9%
0.00%
-100.0%
Q4 2015$28,000
-92.3%
2,700
-96.1%
0.00%
-93.3%
Q4 2013$365,00070,0000.06%
Other shareholders
THERAPEUTICSMD INC shareholders Q2 2020
NameSharesValueWeighting ↓
1492 Capital Management LLC 369,482$2,306,0001.65%
SANDERS MORRIS HARRIS LLC 437,010$2,727,0001.26%
ARDSLEY ADVISORY PARTNERS LP 700,000$4,368,0000.66%
MORGENS WATERFALL VINTIADIS & CO INC 112,000$699,0000.50%
CORRADO ADVISORS, LLC 72,185$450,0000.27%
Redmond Asset Management, LLC 101,309$632,0000.27%
OUTFITTER ADVISORS, LTD. 51,532$322,0000.15%
Mengis Capital Management, Inc. 34,500$215,0000.13%
GREENWOOD CAPITAL ASSOCIATES LLC 86,643$541,0000.12%
Affiance Financial, LLC 25,050$156,0000.12%
View complete list of THERAPEUTICSMD INC shareholders